Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients
Divi's Labs reported Q1 FY27 consolidated revenue of ₹3,144 Cr (up from ₹2,529 Cr YoY) and PAT of ₹902 Cr (up from ₹545 Cr YoY), with 10% constant currency standalone revenue growth. Custom Synthesis drove 60% of revenue. Management is confident in achieving double-digit growth, propelled by three major capex...